Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1 vs 2 Months of Albendazole for Subarachnoid Cysticercosis
NCT00133458Phase 3Withdrawn
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of albendazole in neurocysticercosis (NCC), sponsored by National Institute of Allergy and Infectious Diseases. Status: withdrawn.
02
Drugs
albendazole
03
Conditions
neurocysticercosis (NCC)
Beyond the preview
Go deeper on NCT00133458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133458.